Gradual dose reduction over 4-8 weeks allows the body to readjust, and thyroid levels should be checked both during and after the taper, since weight stabilization changes levothyroxine requirements once again
The dose-response curve explained At the 1mg level, participants lost 8.7% of body weight over 48 weeks
5 Lower doses: Eight in ten real-world patients were on maintenance doses below 1.7 mg of semaglutide or 10 mg of tirzepatide
It's a way to work with your body, not around it
Cora Health vs Ro: the short answer Cora Health and Ro (Ro Body) are both US telehealth platforms that connect patients with licensed providers for GLP-1 weight loss treatment, though as of July 2026 they no longer compete in the same medication category Ro fully exited compounded semaglutide and tirzepatide earlier in 2026 and now sells only FDA-approved branded GLP-1s
New indications, such as cardiovascular risk reduction and obstructive sleep apnea, are redefining the value proposition of these drugs and influencing both prescribing patterns and reimbursement decisions